Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rezvani

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cell Death & Disease|March 15, 2014
Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cellsS Sane, A Abdullah, D A Boudreau, et al.
Leukemia|December 2, 2015
The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemiaR H Rouce, H Shaim, T Sekine, et al.
Bone Marrow Transplantation|April 9, 2014
FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cellsX Liu, S N Robinson, T Setoyama, et al.
Bone Marrow Transplantation|June 4, 2015
Umbilical cord blood graft engineering: challenges and opportunitiesP A Thompson, K Rezvani, C M Hosing, et al.
Bone Marrow Transplantation|May 21, 2013
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCTA J Innes, R Beattie, R Sergeant, et al.
Leukemia|August 17, 2011
KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinibD Marin, I H Gabriel, S Ahmad, et al.
Leukemia|October 4, 2017
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathwayK Kondo, H Shaim, P A Thompson, et al.
Leukemia|July 21, 2017
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activityE Liu, Y Tong, G Dotti, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 27, 2015
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell RecipientsA Abudayyeh, A Hamdi, H Lin, et al.
Science (New York, N.Y.)|November 4, 2017
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patientsV Gopalakrishnan, C N Spencer, L Nezi, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cell Death & Disease|March 15, 2014
Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cellsS Sane, A Abdullah, D A Boudreau, et al.
Leukemia|December 2, 2015
The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemiaR H Rouce, H Shaim, T Sekine, et al.
Bone Marrow Transplantation|April 9, 2014
FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cellsX Liu, S N Robinson, T Setoyama, et al.
Bone Marrow Transplantation|June 4, 2015
Umbilical cord blood graft engineering: challenges and opportunitiesP A Thompson, K Rezvani, C M Hosing, et al.
Bone Marrow Transplantation|May 21, 2013
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCTA J Innes, R Beattie, R Sergeant, et al.
Leukemia|August 17, 2011
KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinibD Marin, I H Gabriel, S Ahmad, et al.
Leukemia|October 4, 2017
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathwayK Kondo, H Shaim, P A Thompson, et al.
Leukemia|July 21, 2017
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activityE Liu, Y Tong, G Dotti, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 27, 2015
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell RecipientsA Abudayyeh, A Hamdi, H Lin, et al.
Science (New York, N.Y.)|November 4, 2017
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patientsV Gopalakrishnan, C N Spencer, L Nezi, et al.
Pageof 3